tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

TMCI Stock Latest News

Treace Medical price target lowered to $4 from $7 at Truist
The FlyTreace Medical price target lowered to $4 from $7 at Truist
20d ago
TMCI
Treace Medical’s Earnings Call: Growth Amid Challenges
PremiumCompany Announcements
Treace Medical’s Earnings Call: Growth Amid Challenges
22d ago
TMCI
Treace Medical price target lowered to $5 from $6 at Stifel
PremiumThe Fly
Treace Medical price target lowered to $5 from $6 at Stifel
23d ago
TMCI
Treace Medical price target lowered to $7.50 from $12 at Lake Street
PremiumThe Fly
Treace Medical price target lowered to $7.50 from $12 at Lake Street
23d ago
TMCI
Treace Medical price target lowered to $5.85 from $6.50 at UBS
PremiumThe Fly
Treace Medical price target lowered to $5.85 from $6.50 at UBS
24d ago
TMCI
Treace Medical downgraded to Neutral from Buy at BTIG
PremiumThe FlyTreace Medical downgraded to Neutral from Buy at BTIG
24d ago
TMCI
Treace Medical downgraded to Underweight from Neutral at JPMorgan
Premium
The Fly
Treace Medical downgraded to Underweight from Neutral at JPMorgan
24d ago
TMCI
Treace Medical Concepts Reports Q3 2025 Financial Results
Premium
Company Announcements
Treace Medical Concepts Reports Q3 2025 Financial Results
24d ago
TMCI
Treace Medical cuts FY25 revenue view to $211M-$213M from $224M-$230M
PremiumThe Fly
Treace Medical cuts FY25 revenue view to $211M-$213M from $224M-$230M
24d ago
TMCI
Treace Medical reports Q3 EPS (26c), consensus (27c)
PremiumThe Fly
Treace Medical reports Q3 EPS (26c), consensus (27c)
24d ago
TMCI
Treace Medical’s Innovative Foot Correction Study: A Potential Game-Changer?
PremiumCompany Announcements
Treace Medical’s Innovative Foot Correction Study: A Potential Game-Changer?
1M ago
TMCI
Treace Medical price target lowered to $7 from $8 at Truist
PremiumThe Fly
Treace Medical price target lowered to $7 from $8 at Truist
2M ago
TMCI
Treace Medical to highlight product innovations, data for ALIGN3D, MTA3D
PremiumThe FlyTreace Medical to highlight product innovations, data for ALIGN3D, MTA3D
3M ago
TMCI
Cautious Optimism for Treace Medical Concepts Amidst New Product Launches and Competitive Risks
Premium
Ratings
Cautious Optimism for Treace Medical Concepts Amidst New Product Launches and Competitive Risks
3M ago
TMCI
Treace Medical price target raised to $8 from $6.60 at Truist
Premium
The Fly
Treace Medical price target raised to $8 from $6.60 at Truist
3M ago
TMCI
Treace Medical Concepts: Positive Q2 Earnings Call Highlights
PremiumCompany Announcements
Treace Medical Concepts: Positive Q2 Earnings Call Highlights
4M ago
TMCI
Treace Medical price target lowered to $6.50 from $8.60 at UBS
PremiumThe Fly
Treace Medical price target lowered to $6.50 from $8.60 at UBS
4M ago
TMCI
Treace Medical Concepts Reports Q2 2025 Financial Results
PremiumCompany Announcements
Treace Medical Concepts Reports Q2 2025 Financial Results
4M ago
TMCI
Treace Medical reports Q2 EPS (28c), consensus (29c)
PremiumThe Fly
Treace Medical reports Q2 EPS (28c), consensus (29c)
4M ago
TMCI
Treace Medical backs FY25 revenue view $224M-$230M, consensus $227.03M
PremiumThe FlyTreace Medical backs FY25 revenue view $224M-$230M, consensus $227.03M
4M ago
TMCI
Treace Medical management to meet virtually with Lake Street
Premium
The Fly
Treace Medical management to meet virtually with Lake Street
4M ago
TMCI
Treace Medical publishes four-year interim results from ALIGN3D study
Premium
The Fly
Treace Medical publishes four-year interim results from ALIGN3D study
4M ago
TMCI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >